Effects of peripherally and centrally applied ghrelin in the pathogenesis of ischemia-reperfusion induced injury of the small intestine

Journal of Physiology and Pharmacology

Volumn 62, Issue 4, 2011, Pages 429-439

  Pawlik, Michal W ^a   Obuchowicz, R ^a   Biernat, J ^a   Szczepanski, W ^a   Pajdo, R ^a   Kwiecien S ^a   Brzozowski, T ^a   Konturek, S J ^a   Pawlik, W W ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Blood flow; Calcitonin gene related peptide; Ghrelin; Intestine; Oxygen uptake; Protection; Sensory afferent nerves

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE FRAGMENT; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CAPSAICIN; GHRELIN; NADOLOL; OXIDOPAMINE; OXYGEN; PLACEBO; UNCLASSIFIED DRUG;

ADRENERGIC NERVE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DENERVATION; DISEASE DURATION; DRUG EFFECT; DRUG MECHANISM; HYPEREMIA; INTESTINE BLOOD FLOW; INTESTINE INJURY; INTESTINE INNERVATION; INTESTINE ISCHEMIA; MALE; MESENTERY BLOOD FLOW; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; PARASYMPATHETIC INNERVATION; PERIPHERAL NERVE INJURY; RAT; REPERFUSION INJURY; SENSORY NERVE CELL; SYMPATHETIC INNERVATION; TISSUE METABOLISM; TREATMENT RESPONSE; VENOUS OXYGEN TENSION;

AFFERENT PATHWAYS; ANIMALS; CAPSAICIN; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; GHRELIN; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MESENTERIC VASCULAR OCCLUSION; MICROCIRCULATION; NEURONS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RECEPTORS, GHRELIN; REPERFUSION INJURY; SPLANCHNIC CIRCULATION; SYMPATHECTOMY, CHEMICAL; TIME FACTORS; VAGOTOMY;

EID: 82155192155     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kozuch PL, Brandt LJ. Diagnosis and management of mesenteric ischemia with an emphasis on pharmacotherapy. Alim Pharm Ther 2005; 21: 201-215.
2. McKinsey IF, Icweriz BI. Acute mesenteric ischemia. Surg Clin North Am 1997; 77: 275-288.
3. Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 2005; 20: 336-343.
4. Weisner W, Khurana B, Hoon I, Ros P. CT of acute bowel ischemia. Radiology 2003; 226: 635-650.
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a novel growth hormone releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
6. Bagnasco M, Dube MG, Kalra PS, Kalra SP. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 2002; 143: 4409-4421.
7. Hewson AK, Dickson SL. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 2000; 12: 1047-1049.
8. Shuto Y, Shibasaki T, Wada K, et al. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci 2001; 68: 991-996.
9. Chang L, Ren Y, Liu X, et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 2004; 43: 165-170.
10. Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsisinduced acute lung injury and mortality in rats. Am J Resp Crit Care Med 2007; 176: 805-813.
11. Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-3807.
12. Katugampola SD, Pallikaros Z, Davenport AP. [125IHis(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 2001; 134: 143-149.
13. Wiley. KH, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-l. Br J Pharmacol 2003; 136: 1146-1152.
14. Sakata I, Yamazaki M, Inoue K, Hayashi Y, Kangawa K, Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett 2003; 342: 183-186.
15. Date MN, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120-1128.
16. Asakawa A; Inui A, Kaga T, et al. Ghrelin is an appetitestimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-345.
17. Banks WA, Tschop M., Robinson S, Heiman M. Extent and direction of ghrelin transport across the blood brain barrier is determined by its unique primary structure. JPET 2002; 302: 822-827.
18. Sibilia V, Rindi G, Pagani F, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-359.
19. Brzozowski T, Konturek PC, Konturek SJ, et al. Exogenous and endogenous ghrelin in gastroprotection against stressinduced gastric damage. Regul Pept 2004; 120: 39-51.
20. Brzozowski T, Konturek PC, Sliwowski Z, et al. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol 2006; 57(Suppl 6): 63-76.
21. Konturek PC, Brzozowski T, Konturek SJ, et al. Role of histamine in ghrelin-induced gastroprotection against acute gastric lesions. Inflamm Res 2007; 56(Suppl 1): 25-26.
22. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006; 57(Suppl 5): 83-96.
23. Holzer P, Livingston EH, Saria A, et al. Sensory nerves mediate protective vasodilatation in the rat gastric mucosa. Am J Physiol 1991; 260: G363-G370.
24. Konturek PC, Brzozowski T, Burnat G, et al. Role of braingut axis in healing of gastric ulcers. J Physiol Pharmacol 2004; 55: 179-192.
25. Walker WF, Homberger DG. Anatomy and Dissection of the Rat. New York, W.H. Freeman and Co., 1998.
26. Brzozowski T, Konturek PC, Sliwowski Z, et al. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 2006; 319: 477-487.
27. De Ambrogi M, Voipe S, Tamanini C. Ghrelin: central and peripheral effects of a novel peptidyl hormone. Med Sci Monit 2003; 9: 217-224.
28. Konturek PC, Brzozowski T. Pajdo R., et al. Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325-336.
29. Ventura-Martinez R, Santiago-Mejia J, Gomez C, Rodriguez R, Fortoul TI. Acute morphological changes in guinea-pig ileum myenteric neurons after ischemia in situ with superfusion in vitro. Pathol Res Pract 2008; 204: 121-127.
30. Hamar J, Racz I, Ciz M, Lojek A, Pallinger E, Furesz J. Time course of leukocyte response and free radical release in an early reperfusion injury of the superior mesenteric artery. Physiol Res 2003; 52: 417-423.
31. Cowley RG, Smith S, Diano M, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661.
32. Wren AM, Small CJ, Fribbens CV, et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002; 76: 316-24.
33. Wu R, Dong W, Ji Y, et al. Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS One 2008; 3: e2026.
34. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 823-839.
35. Konturek P, Brzozowski T, Walter B, et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharm 2006; 536: 171-181.
36. Date M, Kojima H, Hosoda A, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 144: 4255-4261.
37. Fry M, Hoyda T, Ferguson A. Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis. Exp Biol Med 2007; 232.
38. Obuchowicz R, Sendur R, Pawlik M, et al. Myoelectric function, metabolism, intestinal circulation and vagal activity after chemical sympathectomy. Folia Med Cracov 2002; 43: 95-109.
39. Shepherd AP, Pawlik W, Mailman D, Burks TF, Jacobson ED. Effects of vasoconstrictors on intestinal vascular resistance and oxygen extraction. Am J Physiol 1976; 230: 298-305.
40. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol 2003; 54: 561-573.
41. Pawlik WW, Obuchowicz R, Biernat J, Sendur R, Jaworek J. Role of calcitonin gene related peptide in the modulation of intestinal circulatory, metabolic and myoelectric activity during ischemia/reperfusion. J Physiol Pharmacol 2000; 51: 933-942.
42. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin-a new gastroprotective factor in the gastric mucosa. J Physiol Pharmacol 2004; 55: 325-336.
43. Bobryshev P, Bagaeva T, Filaretova L. Ischemic preconditioning attenuates gastric ischemia-reperfusion injury through involvement of glucocorticoids. J Physiol Pharmacol 2009; 60(Suppl 7): 155-160.
44. Nakagiri A, Sunamoto M, Takeuchi K, Murakami M. Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II. J Physiol Pharmacol 2010; 61: 171-179.